news

 

July 2018 AROMICS completes the project on liquid biopsy CTC predict

 
AROMICS completes the project on liquid biopsy CTC predict

AROMICS has successfully completed its project entitled CTC-predict: "Development of a drug screening platform based on circulating tumor cell".

The project is integrated into the general strategy of the company in the ​​oncology area that has two main objectives: (a) the development of new drugs that are more effective and safer; accompanied by (b) new complementary diagnostic tools that improve the diagnosis and / or allow the control of the pharmacological response, improving the management of the disease and allowing the doctors to take decisions about the therapeutic strategy in a personalized way and in real time.

The project granted by ACCIÓ within the program “juts per a projectes en forma de Nuclis de recerca industrial i desenvolupament local i internacional que incentivin la realització d'activitat de recerca industrial i desenvolupament experimental (RD)", has been co-financed the framework of the FEDER Operational Program of Catalonia 2014-2020.